'Pillar Two' reforms boost tax take from Regeneron by €86m
Regeneron in Limerick. Reforms aimed at increasing the corporate tax take from large firms delivered an additional $100m (€86m) in tax from the main Irish unit of the biotechnology giant last year.
Reforms aimed at increasing the corporate tax take from large firms delivered an additional $100m (€86m) in tax from the main Irish unit of biotechnology giant Regeneron last year.
New accounts show that pre-tax profits at Regeneron Ireland DAC last year increased by 56%, from $1.47bn to $4.09bn (€3.55bn).




